Skip to content

Women’s Health logo

Main menu

Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

Her Plan is Her Power

Organon is committed to help prevent 120 million unplanned pregnancies worldwide by 2030.

Illustration of woman with flowers in the background against white backdrop

Accelerating our work to prevent unplanned pregnancies

Nearly half of all pregnancies worldwide (approximately 121 million annually) are estimated to be unplanned, leading to health risks and reduced educational and employment opportunities for mother and child – challenges which can span generations.

Read more

Her Plan is Her Power progress report

Read about our progress across innovation, access and advocacy to help prevent unplanned pregnancies worldwide.

Read our report

Her Promise Access Initiative

Learn about our multi-agency, global effort to expand contraception education, information and availability to 73 of the lowest-income countries.

Read more

Her Promise, Our Purpose

Our purpose is to help women and girls achieve their promise through better health and is inextricably linked to our company vision: to create a better and healthier every day for every woman around the world. By addressing gender-related disparities in health, we build a more sustainable future for women, families, economies and society. Our environmental, social and governance goals focus on three areas: Her Equity, Her Planet, and Her Trust, and the issues that matter most to our stakeholders, our business, and most importantly, women around the world.

Her equity

Throughout the world, women have vast unmet medical needs. Our goal is to redefine and harness innovation to help women and girls achieve their promise and lead healthier, more empowered lives.

Her planet

Women are disproportionately affected by the impact of climate change. They are also more vulnerable to resource scarcity, which is why a healthy planet is important to helping women and girls achieve their promise.

Her trust

To fulfill her promise, we are working to promote balanced gender representation at all levels. We aim to reflect the gender equity within our company that we want to see in the world.

We are here to achieve Her Promise

We are working to achieve a better and healthier every day for every woman through a focus on innovation, access, gender equity and environmental stewardship. Explore our progress in the 2022 ESG Report Executive Summary.

Download our 2022 ESG Report Executive Summary

Connect with us on social

Linkedin icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Women’s Health logo
  • Cookie Policy
  • Cookie Preferences
  • Privacy Policy
  • Terms of Use
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept